Domov › Debelost › Texas › Austin
Klinične študije za Debelost v Austin, TX
20 študij za Debelost išče udeležence na lokacijah v Austin in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 2
- Elligo Clinical Research Center /ID# 282166, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Vključevanje udeležencevFaza 3
- Texas Diabetes & Endocrinology, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Vključevanje udeležencevFaza 3
- Dell Children's Medical Center - PIN, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Vključevanje udeležencevFaza 3
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Vključevanje udeležencevFaza 3
- FutureSearch Trials of Neurology, Austin
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Vključevanje udeležencevFaza 3
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- IMA Clinical Research Austin, Austin
Semaglutide for Post-Smoking Cessation Weight Management
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Vključevanje udeležencevFaza 3
- AURORA-1 Clinical Site, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Vključevanje udeležencevFaza 3
- AURORA-2 Clinical Site, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- Austin Heart, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
- ACCOMPLISH-2 Research Site, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Vključevanje udeležencevFaza 2
- IMA Clinical Research Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Vključevanje udeležencevFaza 3
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Vključevanje udeležencevFaza 3
- Elligo Clinical Research Center, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Austin Heart, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Vključevanje udeležencevFaza 3
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Vključevanje udeležencevFaza 1
- Elligo Clin Res Centre, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Vključevanje udeležencevFaza 1
- Corxel Investigational Site, Austin
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Dell Pediatric Research Center, Austin
- University of Texas at Austin, Austin
Študije za Debelost v drugih mestih
- Houston, TX43 študij
- Chicago, IL41 študij
- New York City, NY40 študij
- San Antonio, TX40 študij
- Washington, DC33 študij
- Orlando, FL31 študij
- Dallas, TX30 študij
- Boston, MA28 študij
- Las Vegas, NV27 študij
- Miami, FL27 študij
- Baltimore, MD25 študij
- Jacksonville, FL25 študij
Druge študije v Austin
- Nemalicelični pljučni rak30 študij
- Rak (vse vrste)20 študij
- Metastatski rak19 študij
- Kolorektalni rak19 študij
- Srčno popuščanje18 študij
- Rak dojke18 študij
- Prekomerna telesna teža18 študij
- Rak jajčnikov17 študij
- Rak endometrija15 študij
- Rak prostate15 študij
- Depresija14 študij
- Trojno negativni rak dojke13 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.